CU22990A3 - PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXADINE - Google Patents

PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXADINE

Info

Publication number
CU22990A3
CU22990A3 CU1999179A CU1999179A CU22990A3 CU 22990 A3 CU22990 A3 CU 22990A3 CU 1999179 A CU1999179 A CU 1999179A CU 1999179 A CU1999179 A CU 1999179A CU 22990 A3 CU22990 A3 CU 22990A3
Authority
CU
Cuba
Prior art keywords
pharmaceutical compositions
formula
tizoxanida
nitazoxadine
particle size
Prior art date
Application number
CU1999179A
Other languages
Spanish (es)
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of CU22990A3 publication Critical patent/CU22990A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmaceútica que contiene como agente activo por lo menos un compuesto seleccionado del grupo integrado la fórmula (I) ESPACIO PARA FÓRMULA y la fórmula (II) ESPACIO PARA FÓRMULA El agente activo tiene preferentemente la forma de partículas con un tamano de partícula menor que 200um y un tamano medio de partícula mayor que 10um. De manera preferente, las composiciones farmaceúticas están estabilizadas con por lo menos un ácido farmaceúticamente aceptable. Las composiciones farmaceúticas de la presente invención son útiles para el tratamiento de infecciones oportunistas en personas con el sistema inmune comprometido o suprimido, así como en el tratamiento de infecciones por tremátodos.The present invention relates to a pharmaceutical composition containing as active agent at least one compound selected from the integrated group the formula (I) FORMULA SPACE and the formula (II) FORMULA SPACE The active agent preferably has the form of particles with a particle size less than 200um and an average particle size greater than 10um. Preferably, the pharmaceutical compositions are stabilized with at least one pharmaceutically acceptable acid. The pharmaceutical compositions of the present invention are useful for the treatment of opportunistic infections in people with the compromised or suppressed immune system, as well as in the treatment of trematode infections.

CU1999179A 1997-05-07 1999-10-29 PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXADINE CU22990A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (1)

Publication Number Publication Date
CU22990A3 true CU22990A3 (en) 2004-09-29

Family

ID=46599548

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1999179A CU22990A3 (en) 1997-05-07 1999-10-29 PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXADINE

Country Status (1)

Country Link
CU (1) CU22990A3 (en)

Similar Documents

Publication Publication Date Title
PY0000172A (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITAZOXANIDE
CO4810223A1 (en) STYLING SHAMPOO COMPOSITIONS
BRPI0009249B8 (en) parenteral pharmaceutical formulation of echinocandin containing micelle-forming surfactants.
DE60019693D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE ABSORPTION-CONNECTING COMPOUNDS
BR0111126A (en) Cyclic amino acid derivatives useful as pharmaceutical agents
MXPA03006999A (en) Mild foaming cleanser composition.
UY25055A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
ATE218581T1 (en) CYCLOSPORINE DERIVATIVE, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION
EP1100522A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES BY PULMONARY TRACT
NO20013402D0 (en) Methods for the treatment of ovarian cancer, poly (phosphoester) preparations, and biodegradable articles thereof
ATE403436T1 (en) POLYCATIONIC CARBOHYDRATES AS IMMUNOSTIMULANT AGENTS IN VACCINES
DE60041753D1 (en) MEDICAMENT FOR THE TREATMENT OF C. PNEUMONIAE INFECTIONS
BR0208017A (en) Combination comprising combretastatin and anticancer agents
CO5140079A1 (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERATION AND METHOD TO RELEASE A PHARMACEUTICALLY ACTIVE AGENT FROM SUSTAINED LIBERATION AND METHOD TO RELEASE A PHARMACEUTICALLY ACTIVE AGENT
DK1280558T3 (en) Semi-solid administration vehicle and pharmaceutical compositions
ES2150404T3 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITOZOXANIDA.
TR200102024T2 (en) New treatment.
CU22990A3 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITAZOXADINE
DOP2000000091A (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANDIA AND NITOZOXANDIA
BRPI0410967A (en) compounds, compositions and their uses for the treatment of virus infections of the family flaviviridae
MY110074A (en) Pharmacuetical formulation.
AR005730A1 (en) FORM OF FANCICLOVIR, PROCEDURE FOR PREPARING IT, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF VIRAL INFECTIONS AND THE USE OF SUCH FORM -FANCICLOVIR MONOIDRATE.
NO20020937D0 (en) Drugs containing xenogenic oligo- and / or polyribonucleotides
ES2179667T3 (en) NEW INJECTABLE FORMULATIONS CONTAINING RAMOPLANIN.
GT200000213A (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITOZOXANIDA